Vistagen Therapeutics Stock (NASDAQ: VTGN) stock price, news, charts, stock research, profile.
Open | $3.61 |
Close | $3.67 |
Volume / Avg. | 177.89K / 111.26K |
Day Range | $3.57 - $3.79 |
52 Wk Range | 2.45 - 7.35 |
Market Cap | $96.05M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 4.3% |
Days to Cover | 7.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vistagen Therapeutics (NASDAQ:VTGN) through any online brokerage.
Other companies in Vistagen Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Tevogen Bio Holdings (NASDAQ:TVGN) and Assembly Biosciences (NASDAQ:ASMB).
Vistagen Therapeutics has a consensus price target of $19.00.
The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $3.5501 last updated August 23, 2024 at 9:25 AM EDT.
There are no upcoming dividends for Vistagen Therapeutics.
Vistagen Therapeutics’s Q2 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Vistagen Therapeutics.
Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.